文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

维生素B6对脓毒症患者的肾脏保护作用及临床分析

RENAL PROTECTIVE EFFECT AND CLINICAL ANALYSIS OF VITAMIN B 6 IN PATIENTS WITH SEPSIS.
PubMed 文献 · Shock · 2024-04-26
一句话结论多中心随机对照研究显示,脓毒症患者静脉给予维生素B6治疗7天后,炎症介质、氧化应激指标及肾功能指标均显著改善,ICU住院时间和总住院费用显著降低,但肾脏替代治疗率和28天死亡率无统计学差异。

该多中心随机对照研究纳入128例符合入组标准的脓毒症患者,在常规治疗基础上随机分为实验组(静脉维生素B6治疗)和对照组(静脉0.9%氯化钠治疗)。治疗7天后,实验组IL-6、IL-8、TNF-α、ET-1水平显著低于对照组,氧化应激指标显著改善,血尿素氮、血清肌酐及超声监测的肾阻力指数显著低于对照组(P<0.05);两组肾脏替代治疗率和28天死亡率无统计学差异(P>0.05);实验组ICU住院时间和总住院费用显著低于对照组(P<0.05)。结论认为维生素B6可减轻脓毒症患者肾损伤,机制可能与吡哆醇降低炎症介质水平及其氧化还原应激调节有关。

要点

  • 多中心随机对照研究纳入128例脓毒症患者,实验组静脉给予维生素B6,对照组静脉给予0.9%氯化钠。
  • 治疗7天后实验组IL-6、IL-8、TNF-α、ET-1水平显著低于对照组(P<0.05)。
  • 治疗7天后实验组血尿素氮、血清肌酐、肾阻力指数显著低于对照组(P<0.05)。
  • 两组肾脏替代治疗率和28天死亡率无统计学差异(P>0.05)。
  • 实验组ICU住院时间和总住院费用显著低于对照组(P<0.05)。

适用人群与场景

  • 符合入组标准的脓毒症患者128例,来自多个中心,随机分为实验组(静脉维生素B6治疗)和对照组(静脉0.9%氯化钠治疗),均接受常规治疗。

处置流程与药物剂量

  • 实验组在常规治疗基础上接受静脉维生素B6治疗,对照组接受静脉0.9%氯化钠治疗,疗程7天。

研究设计与关键结果

  • 多中心随机对照研究,纳入128例脓毒症患者,随机分为实验组(静脉维生素B6治疗)和对照组(静脉0.9%氯化钠治疗),均基于常规治疗。
  • 治疗7天后,实验组IL-6、IL-8、TNF-α、ET-1水平显著低于对照组(P<0.05)。
  • 治疗7天后,实验组氧化应激反应指标显著改善,血尿素氮、血清肌酐、肾阻力指数显著低于对照组(P<0.05)。
  • 两组肾脏替代治疗率和28天死亡率无统计学差异(P>0.05)。
  • 实验组ICU住院时间和总住院费用显著低于对照组(P<0.05)。

证据类型、等级与局限

  • 研究类型:多中心随机对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对脓毒症患者给予维生素B6治疗可减轻肾损伤,机制可能与吡哆醇降低炎症介质水平及其氧化还原应激调节有关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Objective: To investigate the protective effect and possible mechanisms of vitamin B 6 against renal injury in patients with sepsis. Methods: A total of 128 patients with sepsis who met the entry criteria in multiple centers were randomly divided into experimental (intravenous vitamin B 6 therapy) and control (intravenous 0.9% sodium chloride therapy) groups based on usual care. Clinical data, the inflammatory response indicators interleukin 6 (IL-6), interleukin 8 (IL-8), tumor necrosis factor (TNF-α), and endothelin-1 (ET-1), the oxidative stress response indicators superoxide dismutase, glutathione and malondialdehyde, and renal function (assessed by blood urea nitrogen, serum creatinine, and renal resistance index monitored by ultrasound) were compared between the two groups. Results: After 7 d of treatment, the IL-6, IL-8, TNF-α, and ET-1 levels in the experimental group were significantly lower than those in the control group, the oxidative stress response indicators were significantly improved in the experimental group and the blood urea nitrogen, serum creatinine, and renal resistance index values in the experimental group were significantly lower than those in the control group ( P < 0.05). There was no statistical difference between the two groups in the rate of renal replacement therapy and 28 d mortality ( P > 0.05). However, the intensive care unit length of stay and the total hospitalization expenses in the experimental group were significantly lower than those in the control group ( P < 0.05). Conclusion: The administration of vitamin B 6 in the treatment of patients with sepsis attenuates renal injury, and the mechanism may be related to pyridoxine decreasing the levels of inflammatory mediators and their regulation by redox stress.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wang Y, Lu WL, Feng WM, et al. RENAL PROTECTIVE EFFECT AND CLINICAL ANALYSIS OF VITAMIN B 6 IN PATIENTS WITH SEPSIS. Shock. 2024. PMID: 38691102. doi:10.1097/SHK.0000000000002329

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。